ArticleScientific reports2025
Modelling the effects of virus-resistant planting material on the transmission dynamics of banana bunchy top disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- BBTV Nuclear Shuttle Protein Mediates Banana Ubiquitination Pathway Dysregulation.Plants (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Banana bunchy top disease (BBTD) significantly threatens banana production, considerably endangering food safety and security. Aphid vectors and the use of latently infected planting materials disseminate the disease. This paper uses a deterministic mathematical model to examine the BBTD dynamics while considering the Banana Bunchy Top Virus (BBTV)-resistance of the planting material. After model formulation, we establish the positivity and boundedness of the model solution. We derived the effective reproduction number via the next-generation matrix approach and used it to investigate the asymptotic stability of the model equilibrium points using the Lyapunov function. To support the stability results, we conducted a bifurcation analysis. The bifurcation analysis confirmed a forward bifurcation, implying that the disease-free equilibrium point is stable when the effective reproduction number is less than one and unstable when the effective reproduction number is greater than one. The endemic equilibrium point is also stable when the effective reproduction number is greater than one and unstable otherwise. Finally, we apply the fourth-order Runge-Kutta method to simulate the proposed model. One limitation of our research is the need for real data to support our findings. in this instance, we used simulated data from earlier studies to conduct numerical simulations in this study. The results revealed that replanting with BBTV-resistance planting material while the rate of removing symptomatic infected plants is [Formula: see text] reduces the number of latent and symptomatic infected banana plants by [Formula: see text] and [Formula: see text], respectively, in two years. Moreover, it was observed that increasing the rate of roguing to [Formula: see text] and replanting with BBTV-resistant planting material remaining at [Formula: see text] cleared the diseased plants in 10 months. Hence, it eliminates the disease. Therefore, the numerical simulation results suggest that while virus-resistant planting materials alone can reduce disease prevalence, they are most effective when combined with a timely roguing strategy. The results indicate that increasing the number of resistant plants beyond a certain threshold can lead to disease elimination. It is recommended that scientists provide farmers with reliable BBTV-resistant planting material and farming education on the safe way to rogue infected plants and replant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.